GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
PHARMASSET INC. (VRUS) [hlAlert]

Pharmasset, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of
drugs to treat viral infections. It focuses on the development of oral therapeutics for the treatment of hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV).
( Total: 17 Current Stock Recommendations )
PHARMASSET INC.   (17)
Hold 35% Buy 65%
Related companies
Eli Lilly And ...   (29)
Sell Hold 34% Buy 52%
Novartis Ag   (19)
Sell Hold 32% Buy 58%
Pfizer, Inc.   (27)
Sell Hold 22% Buy 70%
TONGITANG CHINESE ...   (2)
Hold 100%
Achillion ...   (15)
Sell Hold 27% Buy 67%
Alcon Inc   (11)
Hold 64% Buy 36%
Bristol-myers ...   (23)
Sell Hold 30% Buy 65%
Johnson & Johnson   (33)
Sell Hold 27% Buy 70%
Prestige Brand ...   (6)
Sell 17% Hold 50% Buy 33%
Merck & Company, ...   (24)
Hold 25% Buy 75%
Filter by Gains:   
  
Rating:
Hold VRUS
up 1,126.79 %

Rating:
Hold VRUS
up 78.57 %

Rating:
Hold VRUS
up 87.12 %
PHARMASSET INC. (VRUS) downgraded to Hold by Brean Murray
Tuesday,  Nov 22, 2011  11:25 AM ET

Rating:
Hold VRUS
PHARMASSET INC. (VRUS) rated Hold by Canaccord Genuity
Tuesday,  Nov 22, 2011  9:25 AM ET

Rating:
Buy VRUS
up 78.57 %
PHARMASSET INC. (VRUS) rated Buy with price target $99 by UBS
Wednesday,  Nov 2, 2011  1:25 PM ET

Rating:
Buy VRUS
up 75.91 %
PHARMASSET INC. (VRUS) rated Buy with price target $95 by UBS
Thursday,  Oct 13, 2011  11:25 AM ET

Rating:
Buy VRUS
up 87.12 %

Rating:
Buy VRUS
up 114.89 %

Rating:
Buy VRUS
up 176.69 %

Rating:
Buy VRUS
up 248.91 %

Rating:
Buy VRUS
up 251.64 %

Rating:
Buy VRUS
up 313.37 %

Rating:
Buy VRUS
up 770.35 %

Rating:
Hold VRUS

Rating:
Buy VRUS
up 770.35 %

Your Recent Stocks
SymbolLastChange
VRUS 136.97 up  0.01 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy